OLMA Olema Pharmaceuticals, Inc. - Common Stock
$10,83
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$5–$36
18% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$40
+271% upside
P/E (TTM)
-5.8
ROE
-39.4%
Nettogewinnmarge
—
OLMA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.82
Marktkapitalisierung
$881M
P/E (TTM)
-5.8
EPS (TTM)
$-1.87
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-39.4%
Verschuldungsgrad
—
52W-Spanne
$5 – $36
OLMA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-1.87
2019-12-31
→
2025-12-31
Freier Cashflow
—
2021-12-31
→
2024-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
OLMA
Peer-Median
P/E (TTM)
-5.8
—
P/B (K/B)
1.8
3.4
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
OLMA
Peer-Median
ROA
-33.0%
-31.3%
ROE
-39.4%
-38.1%
ROIC
-37.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
OLMA
Peer-Median
Current Ratio (Liquiditätsgrad)
10.0
10.9
Quick Ratio
9.8
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
OLMA
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
OLMA
Peer-Median
OLMA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 6 33,3%
- Kauf 10 55,6%
- Halten 2 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-17
Median
$40.00
← Unter allen Zielen
$10.82
Tief
$20.00
Hoch
$62.00
Median-Ziel
$40.00
+269,5%
Mittelwert-Ziel
$40.20
+271,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.61 | $-0.56 | -0.05% |
| 31. März 2026 | $-0.52 | $-0.54 | 0.02% |
| 31. Dezember 2025 | $-0.50 | $-0.54 | 0.04% |
| 30. September 2025 | $-0.49 | $-0.49 | 0.00% |
| 30. Juni 2025 | $-0.51 | $-0.38 | -0.13% |
| 31. März 2025 | $-0.36 | $-0.52 | 0.16% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| DSGN | $567M | -7.7 | — | — | -32.8% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| FTH | — | — | — | — | — | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $158M | $125M | $86M | $82M | $51M | $14M | |
| SG&A Expense | $21M | $18M | $19M | $25M | $20M | $8M | |
| Operating Expenses | $179M | $142M | $105M | $107M | $71M | $22M | |
| Operating Income | $-179M | $-142M | $-105M | $-107M | $-71M | $-22M | |
| Interest Expense | · | · | · | · | · | $653.0K | |
| Interest Income | $16M | $13M | $8M | $2M | $442.0K | $60.0K | |
| Other Non-op | $23.0K | $102.0K | $-19.0K | $-27.0K | $-47.0K | · | |
| Pretax Income | $-162M | $-129M | · | · | · | · | |
| Income Tax | $3.0K | $2.0K | $2.0K | $1.0K | · | · | |
| Net Income | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| EPS (Basic) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| EPS (Diluted) | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 | $-3.42 | |
| Shares (Basic) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| Shares (Diluted) | 87,006,027 | 58,743,522 | 45,247,098 | 39,995,460 | 39,524,272 | 7,021,468 | |
| EBITDA | $-178M | $-142M | $-105M | $-107M | $-71M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $139M | $69M | $24M | $14M | $339M | |
| Short-term Investments | $457M | $295M | $193M | $181M | $273M | · | |
| Prepaid Expense | $10M | $4M | $5M | $4M | $3M | $4M | |
| Current Assets | $515M | $438M | $267M | $209M | $291M | $342M | |
| PP&E (Net) | $274.0K | $746.0K | $968.0K | $1M | $1M | $75.0K | |
| PP&E (Gross) | · | · | · | $2M | $2M | $137.0K | |
| Accum. Depreciation | · | · | · | $581.0K | $224.0K | $62.0K | |
| Other Non-current Assets | · | $15.0K | · | $3M | $540.0K | $510.0K | |
| Total Assets | $533M | $451M | $277M | $216M | $296M | $343M | |
| Accounts Payable | $9M | $4M | $3M | $374.0K | $23.0K | $719.0K | |
| Current Liabilities | $52M | $42M | $22M | $17M | $9M | $5M | |
| Capital Leases | $69.0K | $257.0K | $1M | $2M | $2M | · | |
| Total Liabilities | $55M | $42M | $23M | $18M | $11M | $5M | |
| Common Stock | $8.0K | $7.0K | $4.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.08B | $844M | $559M | $408M | $389M | $371M | |
| Retained Earnings | $-598M | $-435M | $-306M | $-209M | $-104M | $-33M | |
| AOCI | $621.0K | $143.0K | $347.0K | $-2M | $-149.0K | · | |
| Stockholders' Equity | $479M | $409M | $254M | $198M | $285M | $338M | |
| Liabilities + Equity | $533M | $451M | $277M | $216M | $296M | $343M | |
| Shares Outstanding | 81,376,449 | 74,312,608 | 54,992,784 | 40,287,097 | 39,797,263 | 39,308,238 |
Cashflow 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $490.0K | $393.0K | $377.0K | $357.0K | $163.0K | $11.0K | |
| Stock-based Comp | $18M | $23M | $17M | $19M | $16M | $3M | |
| Other Non-cash | $-2M | $2M | $-5M | $4M | $4M | · | |
| Operating Cash Flow | $-147M | $-104M | $-84M | $-82M | $-51M | $-20M | |
| CapEx | · | $159.0K | · | $363.0K | $2M | $56.0K | |
| Investing Cash Flow | $-156M | $-94M | $-5M | $91M | $-275M | $-56.0K | |
| Financing Cash Flow | $211M | $269M | $133M | $476.0K | $1M | $358M | |
| Net Change in Cash | $-91M | $71M | $45M | $10M | $-325M | $338M | |
| Free Cash Flow | · | $-105M | · | $-82M | $-52M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -33.0% | -35.6% | -39.2% | -41.0% | -22.3% | · | |
| ROE | -39.4% | -42.6% | -36.5% | -50.5% | -24.3% | · | |
| ROIC | -37.3% | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 | · | |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-162M | $-129M | $-97M | $-105M | $-71M | $-22M | |
| Market Cap | $2.03B | $433M | $772M | $99M | $373M | · | |
| P/E | -13.4 | -2.6 | -6.6 | -0.9 | -5.2 | -14.1 | |
| P/B | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Tangible Book | 4.3 | 1.1 | 3.0 | 0.5 | 1.3 | · | |
| P / Cash Flow | -13.9 | -4.2 | -9.2 | -1.2 | -7.3 | · | |
| P / FCF | · | -4.1 | · | -1.2 | -7.1 | · | |
| Earnings Yield | -7.5% | -37.7% | -15.2% | -106.9% | -19.2% | -7.1% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $58M | $49M | $43M | $40M | $44M | $31M | $32M | $33M | $29M | $30M | $26M | $19M | $18M | $23M | $22M | $18M | |
| SG&A Expense | $9M | $9M | $7M | $6M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $7M | $6M | $6M | |
| Operating Expenses | $67M | $58M | $50M | $46M | $48M | $35M | $37M | $38M | $34M | $34M | $30M | $23M | $22M | $30M | $27M | $23M | |
| Operating Income | $-67M | $-58M | $-50M | $-46M | $-48M | $-35M | $-37M | $-38M | $-34M | $-34M | $-30M | $-23M | $-22M | $-30M | $-27M | $-23M | |
| Interest Income | $5M | $5M | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $1M | $973.0K | $622.0K | |
| Other Non-op | $-528.0K | $121.0K | $13.0K | $12.0K | $38.0K | $-40.0K | $-93.0K | $138.0K | $40.0K | $17.0K | $93.0K | $-79.0K | $-44.0K | $11.0K | $67.0K | $-120.0K | |
| Net Income | $-63M | $-53M | $-46M | $-42M | $-44M | $-30M | $-34M | $-35M | $-30M | $-31M | $-27M | $-22M | $-20M | $-28M | $-26M | $-23M | |
| EPS (Basic) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| EPS (Diluted) | $-0.61 | $-0.52 | $-0.51 | $-0.49 | $-0.51 | $-0.36 | $-0.50 | $-0.60 | $-0.54 | $-0.56 | $-0.47 | $-0.48 | $-0.49 | $-0.70 | $-0.65 | $-0.57 | |
| Shares (Basic) | 104,453,732 | 102,800,098 | -169,649,843 | 85,732,221 | 85,497,426 | 85,426,223 | -110,376,007 | 57,262,803 | 56,282,402 | 55,574,324 | -80,804,850 | 44,977,161 | 40,720,294 | 40,354,493 | -79,793,579 | 40,036,201 | |
| Shares (Diluted) | 104,453,732 | 102,800,098 | -169,649,843 | 85,732,221 | 85,497,426 | 85,426,223 | -110,376,007 | 57,262,803 | 56,282,402 | 55,574,324 | -80,804,850 | 44,977,161 | 40,720,294 | 40,354,493 | -79,793,579 | 40,036,201 | |
| EBITDA | $-67M | $-58M | · | $-46M | $-48M | $-35M | · | $-38M | $-34M | $-34M | · | $-23M | $-22M | $-30M | · | $-23M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $53M | $48M | $35M | $52M | $51M | $139M | $36M | $17M | $34M | $69M | $117M | $35M | $41M | $24M | $27M | |
| Short-term Investments | $412M | $453M | $457M | $294M | $309M | $342M | $295M | $179M | $222M | $215M | $193M | $159M | $132M | $145M | $181M | $196M | |
| Prepaid Expense | $9M | $8M | $10M | $5M | $6M | $4M | $4M | $3M | $3M | $3M | $5M | $5M | $4M | $3M | $4M | $2M | |
| Current Assets | $470M | $513M | $515M | $334M | $368M | $397M | $438M | $218M | $242M | $252M | $267M | $282M | $172M | $189M | $209M | $225M | |
| PP&E (Net) | $382.0K | $356.0K | $274.0K | $486.0K | $560.0K | $653.0K | $746.0K | $849.0K | $945.0K | $1M | $968.0K | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $698.0K | $744.0K | $681.0K | · | $484.0K | |
| Other Non-current Assets | · | · | · | · | $15.0K | $14.0K | $15.0K | $15.0K | $16.0K | · | · | · | · | $3M | · | $3M | |
| Total Assets | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Accounts Payable | $2M | $4M | $9M | $3M | $934.0K | $151.0K | $4M | $3M | $4M | $8M | $3M | $2M | $2M | $681.0K | $374.0K | $14.0K | |
| Current Liabilities | $53M | $47M | $52M | $42M | $33M | $26M | $42M | $31M | $27M | $26M | $22M | $16M | $15M | $19M | $17M | $13M | |
| Capital Leases | $0 | $0 | $69.0K | $310.0K | $602.0K | $123.0K | $257.0K | $562.0K | $859.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $56M | $50M | $55M | $45M | $37M | $26M | $42M | $31M | $27M | $27M | $23M | $18M | $16M | $21M | $18M | $14M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $1.15B | $1.13B | $1.08B | $858M | $854M | $849M | $844M | $600M | $594M | $573M | $559M | $554M | $419M | $413M | $408M | $403M | |
| Retained Earnings | $-714M | $-651M | $-598M | $-551M | $-509M | $-465M | $-435M | $-402M | $-367M | $-337M | $-306M | $-279M | $-257M | $-237M | $-209M | $-183M | |
| AOCI | $-947.0K | $-460.0K | $621.0K | $526.0K | $314.0K | $420.0K | $143.0K | $464.0K | $-118.0K | $-10.0K | $347.0K | $-241.0K | $-518.0K | $-978.0K | $-2M | $-3M | |
| Stockholders' Equity | $431M | $480M | $479M | $307M | $345M | $383M | $409M | $199M | $227M | $236M | $254M | $275M | $162M | $175M | $198M | $218M | |
| Liabilities + Equity | $487M | $531M | $533M | $352M | $382M | $410M | $451M | $230M | $255M | $264M | $277M | $293M | $178M | $196M | $216M | $232M | |
| Shares Outstanding | 87,452,166 | 87,332,971 | 81,376,449 | 68,652,730 | 68,627,886 | 68,333,065 | 74,312,608 | 57,288,319 | 57,246,411 | 55,867,863 | 54,992,784 | 54,601,516 | 41,122,482 | 40,438,320 | 40,287,097 | 40,084,568 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $102.0K | $119.0K | $187.0K | $43.0K | $132.0K | $128.0K | $116.0K | $95.0K | $94.0K | $88.0K | $88.0K | $90.0K | $99.0K | $100.0K | $97.0K | $91.0K | |
| Stock-based Comp | $13M | $10M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $4M | |
| Other Non-cash | · | $-3M | · | · | · | $-18M | · | · | · | $2M | · | · | · | $3M | · | · | |
| Operating Cash Flow | $-46M | $-46M | $-38M | $-35M | $-30M | $-44M | $-26M | $-27M | $-28M | $-23M | $-18M | $-23M | $-22M | $-20M | $-20M | $-18M | |
| CapEx | · | · | · | $0 | · | · | $0 | $0 | $6.0K | $153.0K | · | · | · | · | $173.0K | $139.0K | |
| Investing Cash Flow | $41M | $5M | $-162M | $17M | $34M | $-45M | $-114M | $46M | $-5M | $-20M | $-31M | $-25M | $14M | $37M | $16M | $20M | |
| Financing Cash Flow | $1M | $46M | $214M | $41.0K | $-3M | $222.0K | $244M | $92.0K | $16M | $9M | $523.0K | $131M | $2M | $220.0K | $273.0K | $106.0K | |
| Net Change in Cash | $-4M | $4M | $13M | $-17M | $2M | $-89M | $104M | $19M | $-17M | $-35M | $-49M | $82M | $-6M | $17M | $-3M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-24M | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.5% | -11.3% | · | -14.5% | -13.8% | -9.0% | · | -13.2% | -14.1% | -13.5% | · | -8.2% | -9.4% | -12.0% | · | -8.4% | |
| ROE | -16.3% | -12.3% | · | -16.7% | -15.3% | -9.8% | · | -14.6% | -15.6% | -15.1% | · | -8.7% | -10.1% | -12.9% | · | -8.8% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 10.9 | · | 8.0 | 11.1 | 15.2 | · | 7.1 | 9.1 | 9.6 | · | 17.7 | 11.6 | 9.8 | · | 17.9 | |
| Quick Ratio | 8.7 | 10.7 | · | 7.9 | 10.9 | 15.1 | · | 7.0 | 9.0 | 9.5 | · | 17.3 | 11.3 | 9.6 | · | 17.7 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-202M | $-169M | · | $-151M | $-139M | $-126M | · | $-117M | $-103M | $-101M | · | $-93M | $-104M | $-107M | · | $-96M | |
| Market Cap | $1.09B | $1.30B | · | $672M | $292M | $257M | · | $684M | $619M | $632M | · | $674M | $371M | $140M | · | $111M | |
| P/E | -5.9 | -7.9 | · | -5.0 | -2.1 | -1.8 | · | -5.5 | -5.2 | -5.1 | · | -5.5 | -3.5 | -1.3 | · | -1.1 | |
| P/B | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Tangible Book | 2.5 | 2.7 | · | 2.2 | 0.8 | 0.7 | · | 3.4 | 2.7 | 2.7 | · | 2.5 | 2.3 | 0.8 | · | 0.5 | |
| P / Cash Flow | · | -28.3 | · | · | · | -5.8 | · | · | · | -26.9 | · | · | · | -6.9 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -26.7 | · | · | · | · | · | · | |
| Earnings Yield | -17.0% | -12.6% | · | -20.0% | -47.2% | -54.8% | · | -18.3% | -19.1% | -19.7% | · | -18.1% | -28.6% | -77.0% | · | -87.7% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-162M | $-129M | $-97M | $-105M | $-71M |
| Verwässerte EPS | $-1.87 | $-2.20 | $-2.14 | $-2.62 | $-1.80 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 10.0 | 10.5 | 12.3 | 12.6 | 32.2 |
| Quick Ratio | 9.8 | 10.4 | 12.1 | 12.4 | 31.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | $-105M | — | $-82M | $-52M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 201 Einreicher · $1.1B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (-20 vs. Vorquartal) | 37 (-10 vs. Vorquartal) | 69 (-1 vs. Vorquartal) | 61 (+6 vs. Vorquartal) | +2.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $109.938.906 | 8.788.082 | 10,35% | Aktien |
| Paradigm Biocapital Advisors LP | $108.468.906 | 8.670.576 | 10,21% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $88.636.465 | 7.085.249 | 8,34% | Aktien |
| VANGUARD GROUP INC | $81.312.975 | 3.252.519 | 7,65% | Aktien |
| BVF INC/IL | $66.251.621 | 5.295.893 | 6,23% | Aktien |
| Siren, L.L.C. | $60.760.432 | 4.856.949 | 5,72% | Aktien |
| STATE STREET CORP | $53.993.886 | 4.316.058 | 5,08% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $41.798.625 | 3.341.217 | 3,93% | Aktien |
| Logos Global Management LP | $40.143.026 | 3.208.875 | 3,78% | Aktien |
| FRANKLIN RESOURCES INC | $29.375.482 | 2.348.160 | 2,76% | Aktien |
| Cormorant Asset Management, LP | $26.896.500 | 2.150.000 | 2,53% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.806.857 | 1.663.218 | 1,96% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $19.640.235 | 1.569.659 | 1,85% | Aktien |
| Deep Track Capital, LP | $18.765.000 | 1.500.000 | 1,77% | Aktien |
| GOLDMAN SACHS GROUP INC | $17.828.551 | 1.425.144 | 1,68% | Aktien |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | $16.954.790 | 1.355.299 | 1,60% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $16.685.012 | 1.333.734 | 1,57% | Aktien |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $15.012.000 | 1.200.000 | 1,41% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $14.154.239 | 1.131.434 | 1,33% | Aktien |
| Point72 Asset Management, L.P. | $13.397.572 | 1.070.949 | 1,26% | Aktien |
| Defilade Capital Management, L.P. | $11.568.723 | 924.758 | 1,09% | Aktien |
| AMERIPRISE FINANCIAL INC | $10.346.508 | 827.059 | 0,97% | Aktien |
| Woodline Partners LP | $9.395.385 | 751.030 | 0,88% | Aktien |
| Candriam S.C.A. | $9.387.633 | 751.133 | 0,88% | Aktien |
| Vivo Capital, LLC | $8.404.756 | 671.843 | 0,79% | Aktien |
| Qube Research & Technologies Ltd | $8.298.121 | 663.319 | 0,78% | Aktien |
| Squarepoint Ops LLC | $7.699.530 | 615.470 | 0,72% | Aktien |
| READYSTATE ASSET MANAGEMENT LP | $7.428.801 | 593.829 | 0,70% | Aktien |
| Jones Hill Capital LP | $7.182.817 | 574.166 | 0,68% | Aktien |
| Hudson Bay Capital Management LP | $7.085.664 | 566.400 | 0,67% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $6.484.458 | 518.342 | 0,61% | Aktien |
| CITADEL ADVISORS LLC | $5.710.252 | 456.455 | 0,54% | Aktien |
| Vestal Point Capital, LP | $5.236.073 | 418.551 | 0,49% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $5.192.338 | 415.055 | 0,49% | Aktien |
| Ikarian Capital, LLC | $4.794.845 | 383.281 | 0,45% | Aktien |
| SEB Asset Management AB | $4.246.649 | 339.461 | 0,40% | Aktien |
| Fisher Asset Management, LLC | $3.712.015 | 296.724 | 0,35% | Aktien |
| BANK OF AMERICA CORP /DE/ | $3.148.342 | 251.666 | 0,30% | Aktien |
| Rock Springs Capital Management LP | $2.942.077 | 235.178 | 0,28% | Aktien |
| Pier Capital, LLC | $2.760.944 | 220.699 | 0,26% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $2.589.432 | 206.989 | 0,24% | Aktien |
| Ikarian Capital, LLC | $2.502.000 | 200.000 | 0,24% | Kaufoption |
| Birchview Capital, LP | $2.489.490 | 199.000 | 0,23% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.280.573 | 182.300 | 0,21% | Verkaufsoption |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $2.024.566 | 161.836 | 0,19% | Aktien |
| HighVista Strategies LLC | $2.003.689 | 160.167 | 0,19% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.847.339 | 147.669 | 0,17% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.784.051 | 142.610 | 0,17% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.665.769 | 133.155 | 0,16% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.563.150 | 124.952 | 0,15% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.530.810 | 102.670 | 0,14% | Aktien |
| CITIGROUP INC | $1.514.173 | 121.037 | 0,14% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.393.142 | 114.192 | 0,13% | Aktien |
| TD Asset Management Inc | $1.328.737 | 106.214 | 0,13% | Aktien |
| Swiss National Bank | $1.313.550 | 105.000 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.297.287 | 103.700 | 0,12% | Kaufoption |
| Integral Health Asset Management, LLC | $1.251.000 | 100.000 | 0,12% | Aktien |
| RHUMBLINE ADVISERS | $1.245.110 | 99.530 | 0,12% | Aktien |
| Trexquant Investment LP | $1.156.074 | 92.412 | 0,11% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.125.775 | 89.990 | 0,11% | Aktien |
| XTX Topco Ltd | $1.119.958 | 89.525 | 0,11% | Aktien |
| TEMA ETFS LLC | $1.112.625 | 44.505 | 0,10% | Aktien |
| ALPS ADVISORS INC | $1.108.999 | 88.649 | 0,10% | Aktien |
| Bank of New York Mellon Corp | $1.071.482 | 85.650 | 0,10% | Aktien |
| BlackRock, Inc. | $1.070.956 | 85.608 | 0,10% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $1.026.195 | 82.030 | 0,10% | Aktien |
| ALGERT GLOBAL LLC | $1.012.409 | 80.928 | 0,10% | Aktien |
| FEDERATED HERMES, INC. | $966.598 | 77.266 | 0,09% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $960.893 | 76.810 | 0,09% | Aktien |
| Rafferty Asset Management, LLC | $944.780 | 75.522 | 0,09% | Aktien |
| ExodusPoint Capital Management, LP | $877.476 | 70.142 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $833.691 | 66.642 | 0,08% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $827.699 | 66.163 | 0,08% | Aktien |
| NOMURA HOLDINGS INC | $825.660 | 66.000 | 0,08% | Verkaufsoption |
| LPL Financial LLC | $737.352 | 58.941 | 0,07% | Aktien |
| Quantinno Capital Management LP | $699.046 | 55.879 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $691.803 | 55.300 | 0,07% | Kaufoption |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $689.564 | 55.121 | 0,06% | Aktien |
| Swedbank AB | $689.301 | 55.100 | 0,06% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $688.050 | 55.000 | 0,06% | Kaufoption |
| Engineers Gate Manager LP | $669.961 | 53.554 | 0,06% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $626.000 | 50.000 | 0,06% | Aktien |
| PORTLAND INVESTMENT COUNSEL INC. | $625.500 | 50.000 | 0,06% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $582.668 | 39.079 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $581.715 | 46.500 | 0,05% | Aktien |
| Headlands Technologies LLC | $515.937 | 41.242 | 0,05% | Aktien |
| NOMURA HOLDINGS INC | $505.404 | 40.400 | 0,05% | Kaufoption |
| PRUDENTIAL FINANCIAL INC | $494.896 | 39.560 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $482.811 | 38.594 | 0,05% | Aktien |
| PROFUND ADVISORS LLC | $479.871 | 38.359 | 0,05% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $469.901 | 37.562 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $451.586 | 36.098 | 0,04% | Aktien |
| JANUS HENDERSON GROUP PLC | $450.716 | 30.219 | 0,04% | Aktien |
| Aristotle Atlantic Partners, LLC | $448.609 | 35.860 | 0,04% | Aktien |
| NOMURA HOLDINGS INC | $423.539 | 33.856 | 0,04% | Aktien |
| Virtus Investment Advisers, LLC | $414.707 | 33.150 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $401.571 | 32.100 | 0,04% | Kaufoption |
| Seven Fleet Capital Management LP | $393.765 | 31.476 | 0,04% | Aktien |
| Invesco Ltd. | $389.224 | 31.113 | 0,04% | Aktien |
| Caption Management, LLC | $375.300 | 30.000 | 0,04% | Kaufoption |
Unternehmensinsider 19 Insider · 7 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sean Bohen | President and CEO | 1. Februar 2023 A | 51.649 | 0 | 0 | $0 |
| Naseem Zojwalla | Chief Medical Officer | 1. Februar 2023 A | — | 0 | 0 | $0 |
| David C. Myles | Chief Development Officer | 1. Februar 2023 A | 154.846 | 0 | 0 | $0 |
| Kinney Horn | Chief Business Officer | 1. Februar 2023 A | — | 0 | 0 | $0 |
| Shane William Charles Kovacs | Ch. Operating & Financial Off. | 1. Februar 2023 A | 358.680 | 0 | 0 | $0 |
| John B Moriarty | EVP, Ch. Legal Officer & Sec. | 1. Februar 2023 A | — | 0 | 0 | $0 |
| Peter J. Kushner | Chief Scientific Officer | 23. November 2020 C | 1.431.672 | 0 | 0 | $0 |
| Cyrus Harmon | Direktor | 24. Juli 2026 S | 702.770 | 0 | 2 | $-291.125 |
| Prakash Raman | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Hrustanovic Gorjan | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Yi Larson | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Graham Walmsley | Direktor | 18. Juni 2026 A | 700.761 | 0 | 0 | $0 |
| Sandra Horning | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Scott J. Garland | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Ian T Clark | Direktor | 18. Juni 2026 A | 0 | 0 | 3 | $-7.873.109 |
| Cynthia M Butitta | Direktor | 18. Juni 2026 A | 83.876 | 0 | 0 | $0 |
| Andrew Rappaport | Direktor | 18. Juni 2026 A | 0 | 0 | 0 | $0 |
| Frank Mccormick | Direktor | 23. November 2020 C | 84.260 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10%-Eigentümer | 23. November 2020 C | 1.725.406 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Logos Global Management LP, Logos Global Management GP LLC, Arsani William, Graham Walmsley, Logos Opportunities GP LLC, Logos GP LLC ×4 Einreichungen | 13. Mai 2025 | 4,70% | Änderung | Passive Anlage | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×4 Einreichungen | 4. Dezember 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 45 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,66% | 81.077 NS | 31. Mai 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,60% | 79.759 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,39% | 141.558 NS | 30. April 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,36% | 11.250 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,32% | 8.351 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 266.015 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 180.516 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 4.753 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,06% | 515.376 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,05% | 2.962 NS | 31. Mai 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 56.779 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,05% | 606.631 SH | 8. August 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,04% | 40.123 NS | 30. April 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 30.271 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 451.269 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 71.008 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 2.004.959 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,03% | 284.227 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 18.801 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 3.287 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,01% | 8.558 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 247.403 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 2.571 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 2.951 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 8.602 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 652.061 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14.261 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 157.394 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 2.602 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 121.187 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17.308 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.374 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 65 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.110 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.299 SH | 8. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 6.974 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 23.513 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 21.603 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 75.925 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 16.063 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 79.886 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 17.373 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 28.000 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.611.290 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.103 SH | 8. August 2026 | Täglich |